KRAS and cancer: Additionally, we examined KRAS E4 alternative splicing patterns across various cancer cell lines and found that nearly all of them predominantly express the KRAS4B splicing variant, in contrast to the broader distribution of E4 inclusion rates observed in the TCGA cancer tissue database analysis.